Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

Li L, Tang J, Zhang B, Yang W, LiuGao M, Wang R, Tan Y, Fan J, Chang Y, Fu J, Jiang F, Chen C, Yang Y, Gu J, Wu D, Guo L, Cao D, Li H, Cao G, Wu M, Zhang MQ, Chen L, Wang H.

Gut. 2015 Jan;64(1):156-67. doi: 10.1136/gutjnl-2013-305715. Epub 2014 Feb 26.

PMID:
24572141
2.

MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition.

Tang J, Li L, Huang W, Sui C, Yang Y, Lin X, Hou G, Chen X, Fu J, Yuan S, Li S, Wen W, Tang S, Cao D, Wu M, Chen L, Wang H.

Cancer Lett. 2015 Aug 1;364(1):33-43. doi: 10.1016/j.canlet.2015.04.023. Epub 2015 Apr 27.

PMID:
25931210
3.

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L.

J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195.

4.

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.

Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.

Carcinogenesis. 2010 May;31(5):766-76. doi: 10.1093/carcin/bgp250. Epub 2009 Oct 20.

PMID:
19843643
5.

Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.

Ji J, Zheng X, Forgues M, Yamashita T, Wauthier EL, Reid LM, Wen X, Song Y, Wei JS, Khan J, Thorgeirsson SS, Wang XW.

Hepatology. 2015 Sep;62(3):829-40. doi: 10.1002/hep.27886. Epub 2015 Jun 30.

6.

Epigenetic regulation of hepatic tumor-initiating cells.

Ding J, Wu J.

Front Biosci (Landmark Ed). 2015 Jun 1;20:946-63. Review.

PMID:
25961535
7.

p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.

Qian YW, Chen Y, Yang W, Fu J, Cao J, Ren YB, Zhu JJ, Su B, Luo T, Zhao XF, Dai RY, Li JJ, Sun W, Wu MC, Feng GS, Wang HY.

Gastroenterology. 2012 Jun;142(7):1547-58.e14. doi: 10.1053/j.gastro.2012.02.042. Epub 2012 Feb 28.

PMID:
22387393
8.

Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation.

Jung CJ, Iyengar S, Blahnik KR, Ajuha TP, Jiang JX, Farnham PJ, Zern M.

PLoS One. 2011;6(11):e27740. doi: 10.1371/journal.pone.0027740. Epub 2011 Nov 28.

9.

MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.

Long XR, He Y, Huang C, Li J.

Int J Oncol. 2014 Jun;44(6):1915-22. doi: 10.3892/ijo.2014.2373. Epub 2014 Apr 8.

PMID:
24714841
10.

Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.

Lee TK, Cheung VC, Ng IO.

Cancer Lett. 2013 Sep 10;338(1):101-9. doi: 10.1016/j.canlet.2012.05.001. Epub 2012 May 8. Review.

PMID:
22579789
11.

Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß.

Qian NS, Liu WH, Lv WP, Xiang X, Su M, Raut V, Chen YL, Dong JH.

PLoS One. 2013 Aug 2;8(8):e68004. doi: 10.1371/journal.pone.0068004. Print 2013.

12.

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.

Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW.

PLoS One. 2013;8(3):e57882. doi: 10.1371/journal.pone.0057882. Epub 2013 Mar 6.

13.

Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.

Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J.

Mol Carcinog. 2014 Dec;53(12):960-9. doi: 10.1002/mc.22064. Epub 2013 Jul 17.

PMID:
23861222
14.

Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.

Wang L, Guo ZY, Zhang R, Xin B, Chen R, Zhao J, Wang T, Wen WH, Jia LT, Yao LB, Yang AG.

Carcinogenesis. 2013 Aug;34(8):1773-81. doi: 10.1093/carcin/bgt139. Epub 2013 Apr 24.

PMID:
23615404
15.

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.

Chen P, Zhao X, Ma L.

Mol Cell Biochem. 2013 Nov;383(1-2):49-58. doi: 10.1007/s11010-013-1753-0. Epub 2013 Jul 11.

PMID:
23842624
16.

MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.

Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, Liu Y, He Y, Park EY, Zhang H, Lv X, Ma K, Su F, Park JH, Song E.

J Biol Chem. 2012 Jan 2;287(1):465-73. doi: 10.1074/jbc.M111.280768. Epub 2011 Nov 10.

17.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
18.

A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.

Zeng C, Wang R, Li D, Lin XJ, Wei QK, Yuan Y, Wang Q, Chen W, Zhuang SM.

Hepatology. 2010 Nov;52(5):1702-12. doi: 10.1002/hep.23875.

PMID:
21038412
19.

Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma.

Lu CY, Lin KY, Tien MT, Wu CT, Uen YH, Tseng TL.

Genes Chromosomes Cancer. 2013 Jul;52(7):636-43. doi: 10.1002/gcc.22059. Epub 2013 Apr 12.

PMID:
23580407
20.

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.

Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W.

Br J Cancer. 2010 Oct 12;103(8):1215-20. doi: 10.1038/sj.bjc.6605895. Epub 2010 Sep 14.

Supplemental Content

Support Center